Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
368
-
Total 13F shares, excl. options
-
67.8M
-
Shares change
-
-1.64M
-
Total reported value, excl. options
-
$7.47B
-
Value change
-
-$154M
-
Put/Call ratio
-
8.05
-
Number of buys
-
194
-
Number of sells
-
-135
-
Price
-
$110.20
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q1 2019
420 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q1 2019.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 368 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.8M shares
of 71.9M outstanding shares and own 94.22% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (8.77M shares), VANGUARD GROUP INC (7.35M shares), BlackRock Inc. (7.11M shares), FRANKLIN RESOURCES INC (4.52M shares), Neuberger Berman Group LLC (2.61M shares), STATE STREET CORP (2.29M shares), ALLIANCEBERNSTEIN L.P. (1.65M shares), BAMCO INC /NY/ (1.6M shares), JPMORGAN CHASE & CO (1.55M shares), and Capital Research Global Investors (1.44M shares).
This table shows the top 368 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.